This is a routine option exercise and sale by a senior executive, not a material insider signal. Monitor for any pattern of larger insider sales in future Form 4 filings, but this single filing is not actionable.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $41.78entry
- T+1 · 11d ago +1.99%α +1.67% · $42.61
- T+5 · 5d ago +4.48%α +1.19% · $43.65
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dov Bergwerk, Teva's Senior VP, General Counsel and Corporate Secretary, filed a Form 144 notice to sell 26,260 ordinary shares with an approximate market value of $1.1 million. The sale is tied to a stock option exercise and sale transaction, executed on the filing date at an indicative price of $41.72 per share. Relative to Teva's $47.4B market cap, the sale is small and routine for an executive exercising options.
Key Facts
- Insider: Dov Bergwerk, Senior VP General Counsel Corporate Secretary
- Shares to be sold: 26,260 ordinary shares
- Approximate value: $1,095,567.20
- Indicative price: $41.72 per share
- Transaction type: stock option exercise and sale
- Filing date: November 4, 2026
- Broker: Citigroup Global Markets, Inc.
Financial Impact
Approximately $1.1 million sale, representing about 0.002% of Teva's $47.4B market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- No context on the insider's remaining holdings, so the proportional impact on his personal position is unknown
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001973379-26-000356 |
| Document: 0001973379-26-000356-index.html | 0001973379-26-000356 |
| Document: 0001973379-26-000356.txt | 0001973379-26-000356 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers